Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CAO Craig Gracey sold 644 shares of Omada Health stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $21.73, for a total value of $13,994.12. Following the transaction, the chief accounting officer directly owned 14,412 shares in the company, valued at approximately $313,172.76. The trade was a 4.28% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.
Craig Gracey also recently made the following trade(s):
- On Monday, August 10th, Craig Gracey sold 1,042 shares of Omada Health stock. The shares were sold at an average price of $25.00, for a total value of $26,050.00.
- On Wednesday, July 1st, Craig Gracey sold 637 shares of Omada Health stock. The shares were sold at an average price of $23.00, for a total value of $14,651.00.
- On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The stock was sold at an average price of $22.00, for a total transaction of $8,910.00.
- On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $21.00, for a total transaction of $43,743.00.
- On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total transaction of $41,680.00.
- On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total transaction of $39,597.83.
- On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total transaction of $37,494.00.
Omada Health Stock Down 8.6%
OMDA stock traded down $1.84 during trading on Friday, reaching $19.66. The stock had a trading volume of 1,647,637 shares, compared to its average volume of 1,252,016. The company has a market capitalization of $1.20 billion, a price-to-earnings ratio of 393.20 and a beta of 1.86. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92. The company’s 50 day moving average is $22.68 and its two-hundred day moving average is $17.91.
Wall Street Analysts Forecast Growth
A number of research firms have recently commented on OMDA. Wall Street Zen upgraded Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Citigroup restated an “outperform” rating on shares of Omada Health in a research report on Friday, August 14th. BTIG Research reaffirmed a “buy” rating and issued a $35.00 price objective on shares of Omada Health in a research report on Friday. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research note on Tuesday, August 11th. Finally, Needham & Company LLC reissued a “buy” rating and set a $28.00 target price on shares of Omada Health in a research report on Friday. Eleven analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $26.67.
View Our Latest Research Report on Omada Health
Institutional Investors Weigh In On Omada Health
Several institutional investors have recently added to or reduced their stakes in the business. Raymond James Financial Inc. bought a new position in Omada Health during the second quarter worth about $32,000. Quarry LP bought a new stake in shares of Omada Health in the fourth quarter valued at approximately $29,000. Integrated Wealth Concepts LLC bought a new stake in shares of Omada Health in the second quarter valued at approximately $53,000. Versant Capital Management Inc lifted its stake in shares of Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after buying an additional 2,283 shares in the last quarter. Finally, Legal & General Group Plc bought a new position in Omada Health in the 2nd quarter worth approximately $76,000.
Key Headlines Impacting Omada Health
Here are the key news stories impacting Omada Health this week:
- Positive Sentiment: Analyst support remains strong: BTIG Research reaffirmed its “buy” rating and set a $35 price target, while Needham & Company also maintained a “buy” rating with a $28 target. These targets imply significant potential upside and reinforce confidence in Omada’s growth outlook.
- Positive Sentiment: Investor Day could provide new growth targets: Omada held its inaugural Investor Day and planned to present updated long-term financial targets. More ambitious revenue, profitability, or membership goals could improve investor confidence if management’s outlook exceeds current expectations. Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
- Neutral Sentiment: Investor Day transcript available: The transcript may offer additional detail on Omada’s strategy and financial targets, but the supplied report does not identify specific changes that would immediately alter earnings expectations. Omada Health Analyst/Investor Day Transcript
- Negative Sentiment: Chief accounting officer sold shares: CAO Craig Gracey sold 644 shares for approximately $14,000, reducing his direct ownership by 4.28%. The relatively small transaction is not necessarily a sign of deteriorating fundamentals, but insider selling can create short-term negative sentiment. SEC Insider Transaction Filing
About Omada Health
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Featured Articles
- Five stocks we like better than Omada Health
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
